The World’s First
Site-Specific Contract Research Organization
(SS-CRO)
CTMG is the world’s first Site-Specific CRO (SS-CRO) with the highest clinical site patient enrollment and retention metrics in the world (to the best of our knowledge). CTMG’s trial management service utilizes our experienced personnel to implement design-reviewed cGMP-like processes, under proprietary layered Quality Systems, at our Business Associate Physician Investigator sites.
Nationally over 70% of clinical sites are either under or non-performing. All other aspects of drug development are required to be conducted utilizing design reviewed process controls under layered Quality Systems, except the final phase when physician investigators implement FDA-approved clinical studies. While these studies are required to be conducted under cGCPs, there are no associated Quality Systems to ensure that what is intended is actually done. Such associated Quality Systems have served the pharmaceutical sponsors well in producing safe, reproducible, auditable study products.
We are the only clinical trial management group that applies these validated processes when conducting clinical trial protocols in physician investigator offices. CTMG’s metrics demonstrate the effectiveness of our “Six Sigma” Quality Systems approach, with 91% of CTMG sites meeting or exceeding contracted enrollment. Because our systems provide physician investigators with complete, auditable infrastructure, even physicians without clinical trial experience have attained excellent metrics utilizing our services.
CTMG currently works with over 100 Business Associate Physician Investigators in North Carolina, Maryland, Washington State, and Virginia in all therapeutic areas.